Management of Cervical Intraepithelial Neoplasia in Pregnant Women

Anticancer Res. 2023 Jul;43(7):3153-3158. doi: 10.21873/anticanres.16488.

Abstract

Background/aim: The aims of the present study were to evaluate the accuracy of colposcopic findings, investigate the way in which untreated cervical intraepithelial neoplasia (CIN) 2/3 develops during pregnancy, and identify factors associated with regression, persistence, or progression rates.

Patients and methods: In a tertiary gynecology and obstetrics department, 655 pregnant women were seen for colposcopy. The most common reason for referral was abnormal cytology findings. The follow-up findings were analyzed retrospectively on the basis of colposcopic findings and cytological and histological tests.

Results: The rate of accuracy for major colposcopic findings was 89.2%. Among the colposcopic findings considered "suspicious for invasion" were invasive carcinoma in 42.9% and CIN 3 in 57.1%. The persistence of CIN 3 postpartum was 80% and the rate of progression 4.1%. The rate of regression for CIN 3 was 21.9%. For CIN 2, the rate of persistence was 37.5%, with a regression rate of 31.3%. The rate of regression was higher after vaginal delivery in comparison with caesarean section.

Conclusion: The accuracy rate of colposcopy is comparatively high, at 89.2%. This might be because pregnant women are seen by more experienced examiners in our dysplasia unit. The rate of progression is comparable with that in other studies. Vaginal delivery increases the regression rate. The newborns' birth weight or birth week did not affect the rates of regression or persistence.

Keywords: High-grade squamous intraepithelial lesion (HSIL); cervical dysplasia; mode of delivery; pregnancy; treatment.

MeSH terms

  • Cesarean Section
  • Colposcopy
  • Female
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Pregnant Women
  • Retrospective Studies
  • Uterine Cervical Dysplasia* / pathology
  • Uterine Cervical Neoplasms* / pathology
  • Vaginal Smears